Pharmacological characterization of an alpha(1A)-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat

被引:81
作者
Lachnit, WG
Tran, AM
Clarke, DE
Ford, APDW
机构
[1] Roche Bioscience, Palo Alto, CA 94304
[2] Institute of Pharmacology, Neurobiology Unit, Roche Bioscience, Palo Alto, CA 94304
关键词
blood vessels; RS-17053; A-61603; SNAP; 5089; prazosin; alpha(1)-adrenoceptor;
D O I
10.1038/sj.bjp.0700983
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The alpha(1)-adrenoceptor population mediating contraction of caudal artery of rat has been characterized by using quantitative receptor pharmacology. 2 Cumulative concentration-effect (E/[A]) curves to noradrenaline (NA) yielded a p[A](50) Of 5.56+/-0.05 (n=16). Prazosin caused concentration-dependent, parallel, dextral shifts of E/[A] curves to NA yielding a pK(b) of 8.9 (Schild regression slope=1.0). RS-17053 (N-[2-(2-cyclopropyl methoxy phenoxy) ethyl]-5-chloro-alpha,alpha-dimethyl -1H-indole- 3-ethanamine hydrochloride; 10-100 nM), a selective alpha(1A)-adrenoceptor antagonist, produced non-parallel, biphasic, dextral shifts of E/[A] curves to NA, suggesting the involvement of more than one alpha(1)-adrenoceptor subtype. Analysis of the high affinity component yielded an apparent pA(2) value of 9.2+/-0.3. 3 A-61603, a selective agonist at alpha(1A) adrenoceptors behaved as a full agonist relative to NA and yielded monophasic E/[A] curves with a p[A(50)] of 7.59+/-0.04 (n=15). Pretreatment of tissues with chloroethylclonidine (CEC; 100 mu M for 20 min, followed by 40 min washout), which preferentially alkylates alpha(1B)- and alpha(1D)-adrenoceptors, did not alter E/[A] curves to A-61603. Prazosin (3-300 nM) caused concentration-dependent, parallel, dextral shifts of E/[A] curves to A-61603 yielding a pA(2) estimate of 9.2+/-0.2. 4 Experiments with alpha(1)-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603. Schild regression analyses yielded pA(2) estimates of 9.2, 9.3, 11.2, 9.0, 6.3, 8.7 and 10.0 for RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739, respectively, although deviations from unit slope (possibly reflecting a secondary involvement of another alpha(1)-adrenoceptor) hindered estimations of pK(b) for some antagonists. The antagonist affinity profile obtained reflects best that described for the alpha(1A)-adrenoceptor. 5 In conclusion, caudal artery of rat contracts in response to NA via activation of at least two alpha(1)-adrenoceptor subtypes. One of these subtypes displays the pharmacology of the alpha(1A)-adrenoceptor, while the other remains to be defined. Use of the novel selective agonist, A-61603, allows for limited pharmacological isolation of the alpha(1A)-adrenoceptor permitting characterization of the properties of selective antagonists.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 42 条
  • [1] INVESTIGATION OF THE SUBTYPES OF ALPHA-1-ADRENOCEPTOR MEDIATING CONTRACTIONS OF RAT AORTA, VAS-DEFERENS AND SPLEEN
    ABOUD, R
    SHAFII, M
    DOCHERTY, JR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) : 80 - 87
  • [2] ALPHA-1 AND ALPHA-2 ADRENOCEPTOR AGONISTS INDUCE VASOCONSTRICTION OF THE NORMOTENSIVE RAT CAUDAL ARTERY INVITRO BY STIMULATION OF A HETEROGENEOUS POPULATION OF ALPHA-1 ADRENOCEPTORS
    ATKINSON, J
    TRESCASES, N
    BENEDEK, C
    BOILLAT, N
    FOUDA, AK
    KRAUSE, F
    PITTON, MC
    RAFIZADEH, C
    DERIVAZ, JC
    SAUTEL, M
    SONNAY, M
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 338 (05) : 529 - 535
  • [3] FUNCTIONAL EVIDENCE EQUATING THE PHARMACOLOGICALLY-DEFINED ALPHA(1A)-ADRENOCEPTOR AND CLONED ALPHA(1C)-ADRENOCEPTOR - STUDIES IN THE ISOLATED-PERFUSED KIDNEY OF RAT
    BLUE, DR
    BONHAUS, DW
    FORD, APDW
    PFISTER, JR
    SHARIF, NA
    SHIEH, IA
    VIMONT, RL
    WILLIAMS, TJ
    CLARKE, DE
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (02) : 283 - 294
  • [4] EVIDENCE FOR A FUNCTIONAL ALPHA(1A)- (ALPHA(1C)-) ADRENOCEPTOR MEDIATING CONTRACTION OF THE RAT EPIDIDYMAL VAS-DEFERENS AND AN ALPHA(1B)-ADRENOCEPTOR MEDIATING CONTRACTION OF THE RAT SPLEEN
    BURT, RP
    CHAPPLE, CR
    MARSHALL, I
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (03) : 467 - 475
  • [5] BYLUND DB, 1994, PHARMACOL REV, V46, P121
  • [6] CRAIG D, 1995, FASEB J, V9, pA106
  • [7] THE ADRENOCEPTOR AGONIST, SDZ NVI 085, DISCRIMINATES BETWEEN ALPHA-1A-ADRENOCEPTOR AND ALPHA-1B-ADRENOCEPTOR SUBTYPES IN VAS-DEFERENS, KIDNEY AND AORTA OF THE RAT
    ELTZE, M
    BOER, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 224 (2-3) : 125 - 136
  • [8] IDENTIFICATION OF ALPHA(1)-ADRENOCEPTOR SUBTYPES PRESENT IN THE HUMAN PROSTATE
    FAURE, C
    PIMOULE, C
    VALLANCIEN, G
    LANGER, SZ
    GRAHAM, D
    [J]. LIFE SCIENCES, 1994, 54 (21) : 1595 - 1605
  • [9] Ford APDW, 1996, BRIT J PHARMACOL, V118, pP29
  • [10] ALPHA-1-ADRENOCEPTOR CLASSIFICATION - SHARPENING OCCAM RAZOR
    FORD, APDW
    WILLIAMS, TJ
    BLUE, DR
    CLARKE, DE
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (06) : 167 - 170